The effects of excluding treatments from network meta-analyses: survey

Objective To examine whether the exclusion of individual treatment comparators, including placebo/no treatment, affects the results of network meta-analysis. Design Survey of networks with individual trial data. Data sources PubMed and communication with authors of network meta-analyses. Study selection and methods We included networks that had five or more treatments, contained at least two closed loops, had at least twice as many studies as treatments, and had trial level data available. Investigators abstracted information about study design, participants, outcomes, network geometry, and the exclusion of eligible treatments. Results Among 18 eligible networks involving 757 randomised controlled trials with 750 possible treatment comparisons, 11 had upfront decided not to consider all treatment comparators and only 10 included placebo/no treatment nodes. In 7/18 networks, there was at least one node whose removal caused a more than 1.10-fold average relative change in the estimated treatments effects, and switches in the top three treatments were observed in 9/18 networks. Removal of placebo/no treatment caused large relative changes of the treatment effects (average change 1.16-3.10-fold) for four of the 10 networks that had originally included placebo/no treatment nodes. Exclusion of current uncommonly used drugs resulted in substantial changes of the treatment effects (average 1.21-fold) in one of three networks on systemic treatments for advanced malignancies. Conclusion Excluding treatments in network meta-analyses sometimes can have important effects on their results and can diminish the usefulness of the research to clinicians if important comparisons are missing.

[1]  M. Bhandari,et al.  Overlapping systematic reviews of anterior cruciate ligament reconstruction comparing hamstring autograft with bone-patellar tendon-bone autograft: why are they different? , 2007, The Journal of bone and joint surgery. American volume.

[2]  Kristian Thorlund,et al.  Multiple treatment comparison meta-analyses: a step forward into complexity , 2011, Clinical epidemiology.

[3]  Kristian Thorlund,et al.  Why the findings of published multiple treatment comparison meta-analyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomings , 2012, Annals of the rheumatic diseases.

[4]  G. Lu,et al.  Combination of direct and indirect evidence in mixed treatment comparisons , 2004, Statistics in medicine.

[5]  Ranking antidepressants , 2009, The Lancet.

[6]  J. Geddes,et al.  Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis , 2009, The Lancet.

[7]  Nicola J Cooper,et al.  Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation. , 2006, Archives of internal medicine.

[8]  S. Feldman,et al.  Efficacy of Systemic Treatments for Moderate to Severe Plaque Psoriasis: Systematic Review and Meta-Analysis , 2009, Dermatology.

[9]  S Dias,et al.  Checking consistency in mixed treatment comparison meta‐analysis , 2010, Statistics in medicine.

[10]  Georgia Salanti,et al.  Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments. , 2006, Journal of the National Cancer Institute.

[11]  D. Symmons,et al.  A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling. , 2006, Health technology assessment.

[12]  G. Brier VERIFICATION OF FORECASTS EXPRESSED IN TERMS OF PROBABILITY , 1950 .

[13]  John P A Ioannidis,et al.  Empirical evaluation of very large treatment effects of medical interventions. , 2012, JAMA.

[14]  B. Psaty,et al.  Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. , 1997, JAMA.

[15]  Tatyana Shamliyan,et al.  Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program. , 2011, Journal of clinical epidemiology.

[16]  Georgia Salanti,et al.  Evaluation of networks of randomized trials , 2008, Statistical methods in medical research.

[17]  R. Rosenthal,et al.  Selective publication of antidepressant trials and its influence on apparent efficacy. , 2008, The New England journal of medicine.

[18]  R. Rafia,et al.  Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation. , 2009, Health technology assessment.

[19]  C. Clar,et al.  The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. , 2009, Health technology assessment.

[20]  S. Sauerland,et al.  Disagreement in primary study selection between systematic reviews on negative pressure wound therapy , 2008, BMC medical research methodology.

[21]  J. Sterne,et al.  How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. , 2003, Health technology assessment.

[22]  Julian P T Higgins,et al.  Evaluation of inconsistency in networks of interventions. , 2013, International journal of epidemiology.

[23]  Georgia Salanti,et al.  Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. , 2011, Journal of clinical epidemiology.

[24]  D. Cook,et al.  A guide to interpreting discordant systematic reviews. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[25]  A. Grant,et al.  Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence. , 2010, Health technology assessment.

[26]  E. A. Nelson,et al.  A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers. , 2006, Health technology assessment.

[27]  A Haycox,et al.  Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation. , 2003, Health technology assessment.

[28]  K. Lohr,et al.  Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians , 2008, Annals of Internal Medicine.

[29]  Georgia Salanti,et al.  Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer. , 2008, Journal of the National Cancer Institute.

[30]  A. Owen,et al.  Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials , 2007, BMJ : British Medical Journal.

[31]  Tina Hernandez-Boussard,et al.  Overlapping meta-analyses on the same topic: survey of published studies , 2013, BMJ.

[32]  Keith Abrams,et al.  Use of Indirect and Mixed Treatment Comparisons for Technology Assessment , 2012, PharmacoEconomics.

[33]  G. Guyatt,et al.  Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. , 1996, JAMA.

[34]  Steffen Fieuws,et al.  Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke. , 2008, European heart journal.

[35]  Massimo Volpe,et al.  Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk. , 2011, Archives of internal medicine.

[36]  M. Puhan,et al.  Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: A systematic review and multiple treatment meta-analysis , 2012, Annals of medicine.

[37]  E. Jones,et al.  Efficacy of telaprevir and boceprevir in treatment-naïve and treatment-experienced genotype 1 chronic hepatitis C patients: an indirect comparison using Bayesian network meta-analysis , 2012, Current medical research and opinion.

[38]  S. Willich,et al.  How objective are systematic reviews? Differences between reviews on complementary medicine. , 2003, Journal of the Royal Society of Medicine.

[39]  Huahao Shen,et al.  Effectiveness of different central venous catheters for catheter-related infections: a network meta-analysis. , 2010, The Journal of hospital infection.

[40]  Edward J Mills,et al.  Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis , 2011, Clinical epidemiology.

[41]  W. Elliott,et al.  Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis , 2007, The Lancet.

[42]  Philippe Ravaud,et al.  Impact of Reporting Bias in Network Meta-Analysis of Antidepressant Placebo-Controlled Trials , 2012, PloS one.

[43]  Georgia Salanti,et al.  Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis. , 2007, The Lancet. Oncology.